Lemer Pax appoints Dr. Konrade von Bremen as Medical Officer for the Lemer Pax Group
Carquefou, 02.10.26 – Press Release
In this highly dynamic period in the field of Nuclear Medicine, Lemer Pax is pleased to announce the appointment of Dr. Konrade von Bremen as Medical Officer for the Lemer Pax Group, effective immediately.
As Medical Officer, Dr. Konrade von Bremen will play a key role in strengthening Lemer Pax’s position as a trusted partner in the rapidly evolving Nuclear Medicine landscape.
Her responsibilities include:
- Promoting the clinical integration of innovative radiation protection equipment in Nuclear Medicine, taking a healthcare-system perspective.
- Promoting the benefits of Lemer Pax equipment for healthcare professionals and patients, with a focus on best-in-class radiation protection solutions.
- Representing Lemer Pax within the industry association Nuclear Medicine Europe (NMEU), where she serves as elected Vice President and EU Affairs Representative.
Dr. Konrade von Bremen, MD, combines a unique clinical background with extensive experience in radiopharmaceuticals, healthcare management, and collaboration between academia and industry.
Until recently, she served as the founding CEO of SWAN Isotopen AG, a radiopharmaceutical company based on the Inselspital campus in Bern, Switzerland. Since 2002, she has been involved in medical research programmes of the European Commission, serving as a programme leader and regularly evaluating medical research projects at the European Commission.
Dr. Konrade von Bremen is committed to strengthening the position of Nuclear Medicine at the European level. Since 2022, she has served as Vice President and EU Affairs Representative of Nuclear Medicine Europe, the European industry association.
She graduated from the University of Siena, Italy, specialised in Internal Medicine in Switzerland, and holds a Master’s degree in Health Economics and Management from the University of Lausanne, Switzerland. She subsequently served as Associate Medical Director at the Lausanne University Hospital (CHUV).
About Lemer Pax
A pioneer in radiation protection calculations and the historic manufacturer of the first shielded hot cells for radioisotope production in France in the 1950s, the Lemer Group has continuously expanded this expertise. With more than 70 years of experience, Lemer Pax offers state-of-the-art solutions, including shielded hot cell production lines for radioisotopes, automated systems for radiopharmaceutical dose preparation and injection, transport containers, and radioactive effluent management systems.
Committed to continuous technological innovation, the company actively contributes to the advancement of practices in Nuclear Medicine, healthcare and civil nuclear applications.
France
